| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Pierre Kyme is Chief Business Officer at ARMP. Pierre Kyme's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $29K at current prices.
Pierre Kyme has 4 Form 4 filings on record from February 2025 to March 2026, all as Chief Business Officer at Armata Pharmaceuticals (ARMP), 2025–2026.
The 4 reported transactions were 2 tax withholdings and 2 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria